4-Acylamino-6-arylfuro[2,3-d]pyrimidines:: potent and selective glycogen synthase kinase-3 inhibitors

被引:39
作者
Maeda, Y
Nakano, M
Sato, H
Miyazaki, Y
Schweiker, SL
Smith, JL
Truesdale, AT
机构
[1] GlaxoSmithKline KK, Tsukuba Res Labs, Dept Chem, Tsukuba, Ibaraki 3004247, Japan
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA
关键词
glycogen synthase kinase-3 inhibitors;
D O I
10.1016/j.bmcl.2004.05.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Modeling studies of a furo[2,3-d]pyrimidine GSK-3 hit compound 1 superimposed onto the X-ray crystal structure of a legacy pyrazolo[3,4-c]pyridazine GSK-3 inhibitor 2 led to the identification of 4-acylamino-6-arylfuro[2,3-d]pyrimidine template 3. Synthesis of analogues based on template 3 has resulted in a number of potent and selective GSK-3beta inhibitors. The most potent and selective compound was the m-pyridyl analogue 24. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3907 / 3911
页数:5
相关论文
共 19 条
[1]  
ADAMS JJ, 2003, Patent No. 022852
[2]   Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription [J].
Coghlan, MP ;
Culbert, AA ;
Cross, DAE ;
Corcoran, SL ;
Yates, JW ;
Pearce, NJ ;
Rausch, OL ;
Murphy, GJ ;
Carter, PS ;
Cox, LR ;
Mills, D ;
Brown, MJ ;
Haigh, D ;
Ward, RW ;
Smith, DG ;
Murray, KJ ;
Reith, AD ;
Holder, JC .
CHEMISTRY & BIOLOGY, 2000, 7 (10) :793-803
[3]   SEPARATION AND CHARACTERIZATION OF GLYCOGEN-SYNTHASE KINASE-3, GLYCOGEN-SYNTHASE KINASE-4 AND GLYCOGEN-SYNTHASE KINASE-5 FROM RABBIT SKELETAL-MUSCLE [J].
COHEN, P ;
YELLOWLEES, D ;
AITKEN, A ;
DONELLADEANA, A ;
HEMMINGS, BA ;
PARKER, PJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 124 (01) :21-35
[4]   The renaissance of GSK3 [J].
Cohen, P ;
Frame, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :769-776
[5]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[6]   Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3β inhibitors [J].
Kuo, GH ;
Prouty, C ;
DeAngelis, A ;
Shen, L ;
O'Neill, DJ ;
Shah, C ;
Connolly, PJ ;
Murray, WV ;
Conway, BR ;
Cheung, P ;
Westover, L ;
Xu, JZ ;
Look, RA ;
Demarest, KT ;
Emanuel, S ;
Middleton, SA ;
Jolliffe, L ;
Beavers, MP ;
Chen, X .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) :4021-4031
[7]   Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease -: A property common to most cycline-dependent kinase inhibitors? [J].
Leclerc, S ;
Garnier, M ;
Hoessel, R ;
Marko, D ;
Bibb, JA ;
Snyder, GL ;
Greengard, P ;
Biernat, J ;
Wu, YZ ;
Mandelkow, EM ;
Eisenbrand, G ;
Meijer, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :251-260
[8]   Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25 [J].
Leost, M ;
Schultz, C ;
Link, A ;
Wu, YZ ;
Biernat, J ;
Mandelkow, EM ;
Bibb, JA ;
Snyder, GL ;
Greengard, P ;
Zaharevitz, DW ;
Gussio, R ;
Senderowicz, AM ;
Sausville, EA ;
Kunick, C ;
Meijer, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (19) :5983-5994
[9]   ALZHEIMER'S DISEASE-LIKE PHOSPHORYLATION OF THE MICROTUBULE-ASSOCIATED PROTEIN TAU BY GLYCOGEN SYNTHASE KINASE-3 IN TRANSFECTED MAMMALIAN CELLS [J].
LOVESTONE, S ;
REYNOLDS, CH ;
LATIMER, D ;
DAVIS, DR ;
ANDERTON, BH ;
GALLO, JM ;
HANGER, D ;
MULOT, S ;
MARQUARDT, B ;
STABEL, S ;
WOODGETT, JR ;
MILLER, CCJ .
CURRENT BIOLOGY, 1994, 4 (12) :1077-1086
[10]   First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease [J].
Martinez, A ;
Alonso, M ;
Castro, A ;
Pérez, C ;
Moreno, FJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (06) :1292-1299